BioMarin price target raised to $60 by HC Wainwright
HC Wainwright & Co. raised its BioMarin Pharmaceutical price target to $60.00/share from $59.00.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.